Open AccessHigh decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection
Author(s) -
Elisabeth Carolle Ngo Bell,
Marie-Anne Vandenhende,
S. Caldato,
A. Saunier,
Pantxika Bellecave,
Camille Tumiotto,
Véronique Avettand-Fènoël,
Mojgan Hessamfar,
Philippe Morlat,
Fabrice Bonnet
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx166
Subject(s) - darunavir , elvitegravir , dolutegravir , medicine , cobicistat , emtricitabine , ritonavir , human immunodeficiency virus (hiv) , renal function , dosing , virology , pharmacology , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom